Replication pattern of the p53 and 21q22 loci in the premalignant and malignant stages of carcinoma of the cervix

Cancer

Volumn 83, Issue 9, 1998, Pages 1966-1971

  Amiel, Aliza ^a,b   Kolodizner, Tania ^a,b   Fishman, Amiram ^a,b   Gaber, Elena ^a,b   Klein, Zvi ^a,b   Beyth, Yoram ^a,b   Fejgin, Moshe D ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Asynchrony; Carcinoma phenotype; Cervical neoplasia; Replication pattern

Indexed keywords

PROTEIN P53;

ARTICLE; CELL SYNCHRONIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA REPLICATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HUMAN; HUMAN CELL; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

CHROMOSOMES, HUMAN, PAIR 21; DNA REPLICATION; FEMALE; GENES, P53; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0032213394     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981101)83:9<1966::AID-CNCR12>3.0.CO;2-E     Document Type: Article

References (26)

1. Goldman MA, Holmquist GP, Gray MC, Gaston LA, Nag A. Replication timing of mammalian genes and middle repet-itive sequences. Science 1984;224:686-92.
2. Holmquist GP. Role of replication time in the control of tissue specific gene expression. Am J Hum Genet 1987;40: 151-73.
3. Hatton KS, Dhar VH, Brown EH, Iqbal MA, Stuart S, Didamo VT, et al. Replication program of active and inactive multigene families in mammalian cells. Mol Cell Biol 1988;8: 2149-58.
4. Braunstein JD, Schulze D, Del Giudice T, Furst A, Schildkraut CL. The temporal order of replication of murine immunoglobulin heavy chain constant region sequences corresponds to their linear order in the genome. Nucleic Acids Res 1982;10:6887-902.
5. Hansen RS, Canfield TK, Lamb MM, Gartler SM, Laird CD. Association of fragile X syndrome with delayed replication of the FMRI gene. Cell 1993;73:1403-9.
6. Selig S, Okumura K, Ward DC, Cedar H. Delineation of DNA replication time zones by fluorescence in situ hybridization. EMBO J 1992;11:1217-25.
7. Kitsberg D, Selig S, Brandeis M, Simon I, Keshet I, Driscoll DJ, et al. Allele-specific replication timing of imprinted gene regions. Nature 1993;364:459-63.
8. Boggs BA, Chinault AC. Analysis of replication timing properties of human X-chromosomal loci by fluorescence in situ hybridization. Proc Natl Acad Sci USA 1994;91:6083-7.
9. Amiel A, Litmanovitch T, Gaber E, Lishner M, Avivi L, Fejgin M. Asynchronous replication of p53 and 21q22 loci in chronic lymphocytic leukemia. Hum Genet 1997;101:219-22.
10. Knoll IHM, Cheng SD, Lalande M. Allele specificity of DNA replication timing in the Angelmann/Prader-Willi syndrome imprinted chromosomal region. Nat Genet 1994;6:41-6.
11. Gunarantne PH, Nakao M, Ledbetter DH, Sutcliffe IS, Chinault AC. Tissue-specific and allele-specific replication timing control in the imprinted human Prader-Willi syndrome region. Genes Dev 1995;9:808-20.
12. White LM, Rogan PK, Nicholls RD, Wu BI, Korf B, Knoll JHM. Allele specific replication of 15q11-q13 loci: a diagnostic test for uniparental disomy. Am J Hum Genet 1996;59:423-30.
13. Chess A, Simon I, Cedar H, Axel R. Allelic inactivation regulates olfactory receptor gene expression. Cell 1994;78:823-34.
14. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991;351:453-6.
15. Dohner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G, et al. p53 gene deletion predicts poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 1995;85:1580-9.
16. National Cancer Institute Workshop. The Bethesda system for reporting cervical/vaginal cytological diagnoses. JAMA 1989;262:931-4.
17. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR. Human papillomavirus type 16 and 18 gene expression in cervical neoplasia. Hum Pathol 1992;23:117-28.
18. Litmanovitch T. Cytogenetic abnormalities observed in ovarian cancer tumors and in non-malignant cells derived from ovarian cancer patients and first degree relatives [Ph.D. thesis]. Tel-Aviv: Tel-Aviv University, 1996.
19. Lichter P, Tang CC, Call K, Hermanson G, Evans GA, Housman D, et al. High resolution mapping of human chromosome 11 by in-situ hybridization with cosmid clones. Science 1990;247:64-9.
20. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983;305: 779-84.
21. Reeve AE, Housiaux PI, Gardner RJ, Chewings WE, Grindley RM, Millow LJ. Loss of a Harvey ras allele in sporadic Wilm's tumor. Nature 1984;309:174-6.
22. Koufos A, Hansen MF, Copeland NG, Jenkins NA, Lampkin BC, Cavenee WK. Loss of heterozygosity in three embryonal tumours suggests a common pathogenic mechanism. Nature 1985;316:330-4.
23. Lundberg C, Skoog L, Cavenee WK, Nordenskjold M. Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13. Proc Natl Acad Sci USA 1987;84:2372-6.
24. Solomon E, Voss R, Hall V, Bodmer WF, Jass JR, Jeffreys AJ, et al. Chromosome 5 allele loss in human colorectal carcinoma. Nature 1987;329:616-9.
25. Naylor SL, Johnson BE, Minna JD, Sakaguchi AY. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature 1987;329:451-4.
26. Moulton T, Chung WY, Yuan L, Hensle T, Waber P, Nisen P, et al. Genomic imprinting and Wilms' tumor. Med Pediatr Oncol 1996;27:476-83.